Did the VeriChip Corporation (then operating as “Applied Digital Solutions”) intentionally fail to provide the cancer studies to the FDA?
Yes, it appears that VeriChip officials intentionally withheld at least two of the cancer studies from their FDA application. Despite repeated claims that the company had no knowledge of any studies linking microchips to cancer, Mr. Silverman later acknowledged to Time Magazine that the company had been aware of one of the most damning cancer studies, the 1999 Blanchard study—and intentionally chose to withhold it from the FDA. According to Time Magazine : “As for the third study [the 1999 Blanchard study in which 10.2% of chipped mice developed cancer around the microchips] , Silverman says it was conducted in mice specifically bred to produce tumors, 39 and was therefore omitted from the sheaf of studies included in the FDA application.” 40 The company could not have made a decision to omit a study from its FDA application unless it knew that the study existed. And since the company knew of the Blanchard study, it must also have known that researcher Keith Johnson in the course of hi
